Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?2.9mm SC, SLActive? 14mm, RXD, Loxi: medical device reports filed with FDA

1,659 reports name it, 2018–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,659
device reports naming the brand
0% of all MAUDE reports · about 197 a year
256
reports, 12 months to August 2026
253 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,659 reports that name the brand "BLT ?2.9mm SC, SLActive? 14mm, RXD, Loxi" (endosseous dental implant), received between February 2018 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

256 reports arrived in the 12 months to August 2026, close to the 253 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (76.3%), loss of osseointegration (11%) and difficult to insert (2.8%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03366Sep 2021: 6Oct 2021: 21Nov 2021: 10Dec 2021: 82022Jan 2022: 11Feb 2022: 25Mar 2022: 21Apr 2022: 20May 2022: 26Jun 2022: 26Jul 2022: 19Aug 2022: 24Sep 2022: 22Oct 2022: 18Nov 2022: 25Dec 2022: 152023Jan 2023: 12Feb 2023: 14Mar 2023: 18Apr 2023: 28May 2023: 34Jun 2023: 22Jul 2023: 14Aug 2023: 19Sep 2023: 9Oct 2023: 23Nov 2023: 17Dec 2023: 202024Jan 2024: 14Feb 2024: 16Mar 2024: 21Apr 2024: 19May 2024: 18Jun 2024: 18Jul 2024: 26Aug 2024: 14Sep 2024: 26Oct 2024: 10Nov 2024: 26Dec 2024: 132025Jan 2025: 16Feb 2025: 21Mar 2025: 23Apr 2025: 9May 2025: 0Jun 2025: 66Jul 2025: 26Aug 2025: 17Sep 2025: 14Oct 2025: 29Nov 2025: 18Dec 2025: 212026Jan 2026: 13Feb 2026: 19Mar 2026: 39Apr 2026: 19May 2026: 16Jun 2026: 18Jul 2026: 25Aug 2026: 25

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01302602018: 7120182019: 13520192020: 16720202021: 14920212022: 25220222023: 23020232024: 22120242025: 26020252026: 1742026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,659
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report72.3%1,199
Voluntary report0%0
User facility report0%0
Distributor report27.7%460
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,26676.3%62.8%
Loss of osseointegration18211%22.4%
Difficult to insertthe device was hard to insert472.8%0.4%
Fracturea broken bone332%1.6%
Separation failure60.4%0.1%
Difficult to removethe device was hard to remove20.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis48329.1%
Painpain, site not specified35421.3%
Tissue damage24414.7%
Inflammationinflammation1307.8%
Swelling/ edema885.3%
Fistula784.7%
Abscessa collection of pus744.5%
Hemorrhage/blood loss/bleeding744.5%
Hyperresponsive to stimuli472.8%
Swellingswelling261.6%
Failure of implant181.1%
Hypersensitivity/allergic reaction171%
Inadequate osseointegration100.6%
Increased sensitivity80.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?2.9mm SC, SLActive? 14mm, RXD, LoxiProduct code DZEAll MAUDE reports
Reports1,6593,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer72.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?2.9mm SC, SLActive? 14mm, RXD, Loxi reports

How many FDA reports name BLT ?2.9mm SC, SLActive? 14mm, RXD, Loxi?

1,659 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 256 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (76.3%), loss of osseointegration (11%), difficult to insert (2.8%), fracture (2%) and separation failure (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (72.3%) and distributor reports (27.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?2.9mm SC, SLActive? 14mm, RXD, Loxi was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.